These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 16076502)
21. Assembling a smallpox biodefense by interrogating 5-substituted pyrimidine nucleoside chemical space. Fan X; Zhang X; Zhou L; Keith KA; Kern ER; Torrence PF Antiviral Res; 2006 Sep; 71(2-3):201-5. PubMed ID: 16759713 [TBL] [Abstract][Full Text] [Related]
22. Antiviral properties of 3-quinolinecarboxamides: a series of novel non-nucleoside antiherpetic agents. Wentland MP; Perni RB; Dorff PH; Brundage RP; Castaldi MJ; Carlson JA; Bailey TR; Aldous SC; Carabateas PM; Bacon ER; Kullnig RK; Young DC; Woods MG; Kingsley SD; Ryan KA; Rosi D; Drozd ML; Dutko FJ Drug Des Discov; 1997 May; 15(1):25-38. PubMed ID: 9332829 [TBL] [Abstract][Full Text] [Related]
23. Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides. Andrei G; Sienaert R; McGuigan C; De Clercq E; Balzarini J; Snoeck R Antimicrob Agents Chemother; 2005 Mar; 49(3):1081-6. PubMed ID: 15728906 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine. Harris SA; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J Antivir Chem Chemother; 2001 Sep; 12(5):293-300. PubMed ID: 11900348 [TBL] [Abstract][Full Text] [Related]
25. Structure-activity relationships for dipeptide prodrugs of acyclovir: implications for prodrug design. Santos CR; Capela R; Pereira CS; Valente E; Gouveia L; Pannecouque C; De Clercq E; Moreira R; Gomes P Eur J Med Chem; 2009 Jun; 44(6):2339-46. PubMed ID: 18848738 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and antiviral evaluation of alkoxyalkyl derivatives of 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine against cytomegalovirus and orthopoxviruses. Beadle JR; Wan WB; Ciesla SL; Keith KA; Hartline C; Kern ER; Hostetler KY J Med Chem; 2006 Mar; 49(6):2010-5. PubMed ID: 16539388 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of anise oil, dwarf-pine oil and chamomile oil against thymidine-kinase-positive and thymidine-kinase-negative herpesviruses. Koch C; Reichling J; Kehm R; Sharaf MM; Zentgraf H; Schneele J; Schnitzler P J Pharm Pharmacol; 2008 Nov; 60(11):1545-50. PubMed ID: 18957177 [TBL] [Abstract][Full Text] [Related]
28. Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro. Smee DF; Bray M; Huggins JW Antivir Chem Chemother; 2001 Nov; 12(6):327-35. PubMed ID: 12018677 [TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo evaluation of isatin-beta-thiosemicarbazone and marboran against vaccinia and cowpox virus infections. Quenelle DC; Keith KA; Kern ER Antiviral Res; 2006 Aug; 71(1):24-30. PubMed ID: 16621041 [TBL] [Abstract][Full Text] [Related]
30. Inhibitory activity of alkoxyalkyl and alkyl esters of cidofovir and cyclic cidofovir against orthopoxvirus replication in vitro. Keith KA; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER Antimicrob Agents Chemother; 2004 May; 48(5):1869-71. PubMed ID: 15105146 [TBL] [Abstract][Full Text] [Related]
31. In vitro antiviral activity of Chamaecrista nictitans (Fabaceae) against herpes simplex virus: biological characterization of mechanisms of action. Herrero Uribe L; Chaves Olarte E; Tamayo Castillo G Rev Biol Trop; 2004 Sep; 52(3):807-16. PubMed ID: 17361573 [TBL] [Abstract][Full Text] [Related]
33. Amphipathic DNA polymers are candidate vaginal microbicides and block herpes simplex virus binding, entry and viral gene expression. Guzman EM; Cheshenko N; Shende V; Keller MJ; Goyette N; Juteau JM; Boivin G; Vaillant A; Herold BC Antivir Ther; 2007; 12(8):1147-56. PubMed ID: 18240855 [TBL] [Abstract][Full Text] [Related]
34. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication. Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112 [TBL] [Abstract][Full Text] [Related]
35. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons. Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives. Cheng J; Xie J; Luo X Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937 [TBL] [Abstract][Full Text] [Related]
37. Antiviral evaluation of N-amino-1,2,3-triazoles against Cantagalo virus replication in cell culture. Jordão AK; Afonso PP; Ferreira VF; de Souza MC; Almeida MC; Beltrame CO; Paiva DP; Wardell SM; Wardell JL; Tiekink ER; Damaso CR; Cunha AC Eur J Med Chem; 2009 Sep; 44(9):3777-83. PubMed ID: 19481841 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and antiviral activities of new acyclic and "double-headed" nucleoside analogues. Zhang X; Amer A; Fan X; Balzarini J; Neyts J; De Clercq E; Prichard M; Kern E; Torrence PF Bioorg Chem; 2007 Jun; 35(3):221-32. PubMed ID: 17270235 [TBL] [Abstract][Full Text] [Related]
39. (E)-5-(2'-bromovinyl)-2'-deoxyuridine inhibition of macropodid herpesvirus 1 in vitro. Smith GA; Whalley JM J Zoo Wildl Med; 1998 Jun; 29(2):157-9. PubMed ID: 9732029 [TBL] [Abstract][Full Text] [Related]
40. KAY-2-41, a novel nucleoside analogue inhibitor of orthopoxviruses in vitro and in vivo. Duraffour S; Drillien R; Haraguchi K; Balzarini J; Topalis D; van den Oord JJ; Andrei G; Snoeck R Antimicrob Agents Chemother; 2014; 58(1):27-37. PubMed ID: 24126587 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]